Epidemiology of thyroid carcinoma over the world;Épidémiologie des cancers thyroïdiens dans le monde

Annales d'Endocrinologie

Volumn 72, Issue 2, 2011, Pages 136-148

  Leenhardt, L ^a   Grosclaude, P ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Cancer thyro dien; Facteurs de risque; Incidence; Mortalit ; Pratiques cliniques; Taille tumorale

Indexed keywords

ENVIRONMENTAL CHEMICAL;

ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CANCER SIZE; CYTOLOGY; ECHOGRAPHY; FRANCE; GEOGRAPHIC DISTRIBUTION; HUMAN; METASTASIS; PREOPERATIVE EVALUATION; RISK FACTOR; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADOLESCENT; ADULT; AGED; CHERNOBYL NUCLEAR ACCIDENT; FEMALE; FRANCE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; REGISTRIES; RISK FACTORS; THYROID NEOPLASMS; THYROIDECTOMY; WORLD HEALTH; YOUNG ADULT;

EID: 79955730967     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2011.03.025     Document Type: Article

References (50)

1. Gilliland F.D., Hunt W.C., Morris D.M., Key C.R. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the surveillance, epidemiology and end results (SEER) program 1973-1991. Cancer 1997, 79:564-573.
2. Hundahl S.A., Cady B., Cunningham M.P., Mazzaferri E., McKee R.F., Rosai J., et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996 U. S. and German thyroid cancer study group. An American College of surgeons commission on cancer patient care evaluation study. Cancer 2000, 89:202-217.
3. Schlumberger M. Papillary and follicular thyroid carcinoma. N Engl J Med 1998, 338:297-306.
4. Kilfoy B.A., Zheng T., Holford T.R., Han X., Ward M.H., Sjodin A., et al. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 2009, 20:525-531.
5. Truong T., Rougier Y., Dubourdieu D., Guihenneuc-Jouyaux C., Orsi L., Hemon D., et al. Time trends and geographic variations for thyroid cancer in New Caledonia, a very high incidence area (1985-1999). Eur J Cancer Prev 2007, 16:62-70.
6. Colonna M., Grosclaude P., Remontet L., Schvartz C., Mace-Lesech J., Velten M., et al. Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997). Eur J Cancer 2002, 38:1762-1768.
7. De Vathaire F., Hardiman C., Shamsaldin A., Campbell S., Grimaud E., Hawkins M., et al. Thyroid carcinomas after irradiation for a first cancer during childhood. Arch Intern Med 1999, 159:2713-2719.
8. Ron E., Lubin J.H., Shore R.E., Mabuchi K., Modan B., Pottern L.M., et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiation Research 1995, 141:259-277.
9. Leenhardt L., Aurengo A. Post-Chernobyl thyroid carcinoma in children. Baillieres Best Pract Res Clin Endocrinol Metab 2000, 14:667-677.
10. D'Avanzo B., La Vecchia C., Franceschi S., Negri E., Talamini R. History of thyroid diseases and subsequent thyroid cancer risk. Cancer Epidemiol Biomarkers Prev 1995, 4:193-199.
11. Kravdal O., Glattre E., Haldorsen T. Positive correlation between parity and incidence of thyroid cancer: new evidence based on complete Norwegian birth cohorts. Int J Cancer 1991, 49:831-836.
12. Spitz M.R., Sider J.G., Katz R.L., Pollack E.S., Newell GR Ethnic patterns of thyroid cancer incidence in the United States, 1973-1981. Int J Cancer 1988, 42:549-553.
13. Colonna M., Bossard N., Guizard A.V., Remontet L., Grosclaude P Descriptive epidemiology of thyroid cancer in France: incidence, mortality and survival. Ann Endocrinol 2010, 71:69-130.
14. Sassolas G., Hafdi-Nejjari Z., Remontet L., Bossard N., Belot A., Berger-Dutrieux N., et al. Thyroid cancer: is the incidence rise abating?. Eur J Endocrinol 2009, 160:71-79.
15. Colonna M., Guizard A.V., Schvartz C., Velten M., Raverdy N., Molinie F., et al. A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983-2000). Eur J Cancer 2007, 43:891-900.
16. Colonna M., Grande E., Jonasson J.G., Eurocare Working G. Variation in relative survival of thyroid cancers in Europe: results from the analysis on 21 countries over the period 1983-1994 (Eurocare-3 study). Eur J Cancer 2006, 42:2598-2608.
17. Hakulinen T., Andersen A., Malker B., Pukkala E., Schou G., Tulinius H. Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic cancer registries. Acta Pathol Microbiol Immunol Scand Suppl 1986, 288:1-151.
18. Glattre E., Akslen L.A., Thoresen S.O., Haldoren T. Geographic patterns and trends in the incidence of thyroid cancer in Norway 1970-1986. Cancer Detect Prev 1990, 14:625-631.
19. Akslen L.A., Haldorsen T., Thoresen S.O., Glattre E. Incidence of thyroid cancer in Norway 1970-1985. Population review on time trend, sex, age, histological type and tumour stage in 2625 cases. Apmis 1990, 98:549-558.
20. Pettersson B., Adami H.O., Wilander E., Coleman M.P. Trends in thyroid cancer incidence in Sweden, 1958-1981, by histopathologic type. Int J Cancer 1991, 48:28-33.
21. dos Santos Silva I., Swerdlow A.J. Thyroid cancer epidemiology in England and Wales: time trends and geographical distribution. Br J Cancer 1993, 67:330-340.
22. Lund E., Galanti MR Incidence of thyroid cancer in Scandinavia following fallout from atomic bomb testing: an analysis of birth cohorts. Cancer Causes Control 1999, 10:181-187.
23. Zhu C., Zheng T., Kilfoy B.A., Han X., Ma S., Ba Y., et al. A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004. Thyroid 2009, 19:1061-1066.
24. Davies L., Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973-2002. Jama 2006, 295:2164-2167.
25. Kent W.D., Hall S.F., Isotalo P.A., Houlden R.L., George R.L., Groome P.A. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. Cmaj 2007, 177:1357-1361.
26. Chen A.Y., Jemal A., Ward E.M. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009, 115:3801-3807.
27. Enewold L., Zhu K., Ron E., Marrogi A.J., Stojadinovic A., Peoples G.E., et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 2009, 18:784-791.
28. Leenhardt L., Bernier M.O., Boin-Pineau M., Conte Devolx B., Maréchaud R., Niccoli-Sire P., et al. Advances in diagnostic practices affect thyroid cancer incidence in France. Eur J Endocrinol 2004, 150:133-139.
29. Leenhardt L., Grosclaude P., Cherie-Challine L. Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French thyroid cancer committee. Thyroid 2004, 14:1056-1060.
30. Leenhardt L., Menegaux F., Fran B., Delbot T., Mansour G., Hoang C., et al. Selection of patients with solitary thyroid nodules for operation. Eur J Surg 2002, 168:236-241.
31. Sassolas G., Hafdi-Nejjari Z., Schott A.M., Bournaud C., Peix J.L., Orgiazzi J., et al. Geographical correlation between incidence of benign disease and that of cancer of the thyroid among the population of the Rhone-Alpes Region of France. Eur J Endocrinol 2010, 162:127-135.
32. Verkooijen H.M., Fioretta G., Pache J.C., Franceschi S., Raymond L., Schubert H., et al. Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva Switzerland. Cancer Causes Control 2003, 14:13-17.
33. Rego-Iraeta A., Perez-Mendez L.F., Mantinan B., Garcia-Mayor R.V. Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma. Thyroid 2009, 19:333-340.
34. Leenhardt L., Grosclaude P., Chérié-Challine L. Guidelines for a national epidemiological surveillance system of thyroid cancer in France 2003, Public Health Agency, Paris, p. 1-211.
35. Cardis E., Kesminiene A., Ivanov V., Malakhova I., Shibata Y., Khrouch V., et al. Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst 2005, 97:724-732.
36. Lundell M., Hakulinen T., Holm L.E. Thyroid cancer after radiotherapy for skin hemangioma in infancy. Radiat Res 1994, 140:334-339.
37. Lindberg S., Karlsson P., Arvidsson B., Holmberg E., Lunberg L.M., Wallgren A. Cancer incidence after radiotherapy for skin haemangioma during infancy. Acta Oncol 1995, 34:735-740.
38. Nikiforov Y.E. Is ionizing radiation responsible for the increasing incidence of thyroid cancer?. Cancer 2010, 116:1626-1628.
39. Parkin D., Whelan S., Ferlay J., Raymond L., Young J. Cancer incidence in five continents 1997, Sci Pub, Lyon, n°143. Vol VII.
40. Brindel P., Doyon F., Bourgain C., Rachedi F., Boissin J.L., Sebbag J., et al. Family history of thyroid cancer and the risk of differentiated thyroid cancer in French polynesia. Thyroid 2010, 20:393-400.
41. Bosetti C., Kolonel L., Negri E., Ron E., Franceschi S., Dal Maso L., et al. A pooled analysis of case-control studies of thyroid cancer VI. Fish and shellfish consumption. Cancer Causes Control 2001, 12:375-382.
42. Franceschi S., Fassina A., Talamini R., Mazzolini A., Vianello S., Bidoli E., et al. The influence of reproductive and hormonal factors on thyroid cancer in women. Rev Epidemiol Sante Publique 1990, 38:27-34.
43. Levi F., Franceschi S., La Vecchia C., Negri E., Gulie C., Duruz G., et al. Previous thyroid disease and risk of thyroid cancer in Switzerland. Eur J Cancer 1991, 27:85-88.
44. Preston-Martin S., Jin F., Duda M.J., Mack W.J. A case-control study of thyroid cancer in women under age 55 in Shanghai (People's Republic of China). Cancer Causes Control 1993, 4:431-440.
45. Vriens M.R., Suh I., Moses W., Kebebew E. Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer. Thyroid 2009, 19:1343-1349.
46. Schlumberger M Thyroid tumors 2003, PF, Paris.
47. Franceschi S., Preston-Martin S., Dal Maso L., Negri E., La Vecchia C., Mack W.J., et al. A pooled analysis of case-control studies of thyroid cancer IV. Benign thyroid diseases. Cancer Causes Control 1999, 10:583-595.
48. Brindel P., Doyon F., Rachedi F., Boissin J.L., Sebbag J., Shan L., et al. Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in native women in French Polynesia: a population-based case-control study. Am J Epidemiol 2008, 167:219-229.
49. Brindel P., Doyon F., Rachedi F., Boissin J.L., Sebbag J., Shan L., et al. Anthropometric factors in differentiated thyroid cancer in French Polynesia: a case-control study. Cancer Causes Control 2009, 20:581-590.
50. Leux C., Guenel P. Risk factors of thyroid tumors: role of environmental and occupational exposures to chemical pollutants. Rev Epidemiol Sante Publique 2010, 58:359-367.